Erythritol (C4H10O4; molar mass 122.12 g/mol) enters direct compression formulation as a non-hygroscopic crystalline polyol filler with a true density of 1.43–1.45 g/cm³ measured by helium pycnometry in accordance with USP 699, an aqueous solubility of 61 g/100 mL at 25 °C, and a melting endotherm peak between 119 °C and 121 °C when determined by differential scanning calorimetry at 10 K/min under ISO 11357-1. Direct compression grades of erythritol are generally produced by recrystallization and controlled milling, yielding particles with a median particle size by laser diffraction of 25–200 µm under ISO 13320, specific surface areas of 0.2–0.8 m²/g by nitrogen adsorption under ISO 9277, bulk densities of 0.45–0.60 g/mL and tapped densities of 0.60–0.75 g/mL under USP 616. The corresponding Carr’s compressibility index typically falls between 15% and 25% and the angle of repose between 32° and 38° under USP 1174, indicating fair to passable flow without uncontrolled hopper agitation. Moisture uptake for this filler is below 0.5% w/w after 24 h at 25 °C and 80% RH in gravimetric sorption studies aligned with USP 922; this is a meaningful contrast to mannitol-based direct compression grades, which may adsorb surface moisture more readily although both remain classified as non-hygroscopic for most practical purposes. The low moisture affinity of erythritol is not an unconditional exemption from process humidity controls, because crystalline powders can still acquire static charge, form agglomerates, and exhibit altered bulk friction at relative humidities above 60%; however, the risk of moisture-mediated plasticization of amorphous domains is negligible when the amorphous content is controlled below 0.5% w/w by X-ray powder diffraction or differential scanning calorimetry.
| Parameter | Reported range or value | Measurement standard or equipment |
|---|---|---|
| Molar mass | 122.12 g/mol | Certificate of analysis |
| Melting endotherm peak | 119–121 °C | ISO 11357-1, DSC at 10 K/min |
| Aqueous solubility | 61 g/100 mL at 25 °C | Shake-flask equilibrium, USP 1236 adaptation |
| True density | 1.43–1.45 g/cm³ | USP 699, helium pycnometry |
| Bulk density | 0.45–0.60 g/mL | USP 616 Method I |
| Tapped density | 0.60–0.75 g/mL | USP 616 Method II, 1250 taps |
| Specific surface area | 0.2–0.8 m²/g | ISO 9277, nitrogen adsorption |
| Median particle size, direct compression grade | 25–200 µm | ISO 13320, laser diffraction |
| Carr’s compressibility index | 15–25% | USP 1174 |
| Angle of repose | 32–38° | USP 1174 |
| Moisture uptake at 25 °C/80% RH for 24 h | <0.5% w/w | USP 922 adaptation, gravimetric sorption |
The compaction behavior of erythritol is governed by brittle fragmentation rather than viscoelastic or plastic flow. Under instrumented uniaxial compression, the powder bed first undergoes particle rearrangement at low pressures; at higher pressures the crystals fracture into smaller fragments, generating new surfaces and increasing interparticulate contact area. This mechanism is distinct from the plastic deformation observed with microcrystalline cellulose or the time-dependent viscoelasticity of some co-processed fillers. A practical consequence is that erythritol compacts can exhibit a plateau in diametral crushing strength even as compression force increases, because fragmentation creates bonding surfaces but the low intrinsic ductility limits the ability to form continuous interparticulate bonds. Published Heckel analyses for erythritol-based direct compression systems are limited, but the brittle consolidation behavior is generally associated with yield pressures above 300 MPa at low punch velocities, and apparent yield pressures increase further at short dwell times on high-speed rotary presses. Tablet tensile strength is calculated from diametral compression using the relationship σ = 2P/(πDt), where P is the breaking load, D is the tablet diameter, and t is the tablet thickness; erythritol tablets produced without a dry binder often fail below 1.5 MPa tensile strength even at compression pressures approaching 250 MPa. This low compactibility imposes a direct binding requirement or the use of a co-processed erythritol grade when the formulation requires robust handling in automated packaging.
The principal constraint in plain erythritol direct compression is the narrow processing window between sufficient breaking force and capping or lamination. When flat-faced, bevel-edged 10.00 mm tablets are compressed on an instrumented single-punch press to 150 MPa, the resulting compacts can show immediate axial elastic recovery of 3–5% and radial recovery of 0.8–1.2%; these recovery values are high enough to create internal shear planes if the final tablet porosity falls below approximately 0.12. On a rotary tablet press, the situation is more severe because the decompression phase occurs more rapidly than on a single-punch machine, and the feed frame does not provide sufficient dwell time for stress relaxation. Precompression is therefore used to consolidate the fragile primary particles before main compression, with precompression forces typically maintained at 20–30% of the main compression force. When precompression exceeds 35% of the main force, the upper punch may encounter already compacted material with reduced particle rearrangement capacity, and ejection forces rise. Documented production-scale cases describe die bore polishing and reduced punch-tip concavity as necessary adjustments when plain erythritol formulations are run above 40 rpm on a 29-station rotary press equipped with B-tooling; otherwise the incidence of crown cracking rises disproportionately. Published data for lamination thresholds in this specific configuration is limited, so process qualification should rely on hydraulic press compaction profiles, instrumented rotary press force-displacement signatures, and friability results below 0.8% after 100 rotations under USP 1216.
Particle size distribution exerts a controlling influence on erythritol compactibility. Fine fractions below 45 µm increase the total bonding area after fragmentation, but they also increase die fill variability and reduce flow, particularly in rotary machines using gravity feed frames. Coarse fractions above 150 µm improve flow but can leave visible surface defects and reduce tensile strength by 20–30% relative to a grade with a D50 near 80–100 µm. Direct compression formulations containing erythritol without a dry binder frequently require a filler-binder such as microcrystalline cellulose at 20–40 wt%, copovidone at 2–5 wt%, or pregelatinized starch at 5–15 wt% to raise compact tensile strength above 2.0 MPa. The dry binder also absorbs some of the elastic recovery energy and distributes compaction strain more evenly through the compact. In binary blends with microcrystalline cellulose, the Heckel yield pressure is reduced relative to plain erythritol, indicating that the composite consolidates more efficiently at production speeds; however, the moisture uptake of the final blend then becomes dominated by the cellulosic fraction, partially eroding the non-hygroscopic advantage if not controlled by humidified process air below 30% RH.
Lubrication further complicates the compaction profile. Magnesium stearate at 0.5–1.0 wt% is typically required to prevent picking and reduce ejection forces. Because erythritol consolidates by fragmentation rather than plastic deformation, it is less sensitive to lubricant-induced weakening than microcrystalline cellulose, but the benefit is lost if the lubricant is overblended. When a 300 L bin blender is operated at 12 rpm for more than 20 min after adding magnesium stearate, the compact tensile strength of erythritol-based tablets can fall by 10–15% relative to a 3 min lubrication step. The preferred approach is to preblend erythritol, filler-binder, disintegrant, and active ingredient for 20–30 min, then add magnesium stearate through a 600 µm sieve and continue blending for only 3–5 min. Ejection forces for unlubricated erythritol compacts can exceed 1000 N on 10.00 mm round tooling; with 0.5 wt% magnesium stearate, steady-state ejection forces generally fall below 500 N on a production rotary press equipped with a standard take-off blade. These values are specific to the tool geometry and punch hardness, and published data for alternative punch coatings is limited.
The selection of erythritol becomes defensible when the active pharmaceutical ingredient undergoes hydrolysis or moisture-mediated polymorphic change in the presence of hygroscopic fillers. Hydrolysis-prone actives such as acetylsalicylic acid or proton-pump inhibitors require water activity control throughout blending, compression, and primary packaging. In such formulations, erythritol at 50–85 wt% functions as a low-moisture bulking agent, and the immediate tablet environment remains below 20% RH when measured by headspace water activity using tunable diode laser absorption spectroscopy or capacitive sensors. The compact itself must still disintegrate within a pharmacopoeial limit; plain erythritol is water-soluble, so the dissolution and disintegration front is controlled by the disintegrant network rather than by swelling of the filler. Crospovidone at 2–5 wt% or croscarmellose sodium at 2–6 wt% is included to meet a disintegration time below 15 min for immediate-release tablets under USP 701. The non-hygroscopic filler reduces the thermodynamic water available for hydrolysis, but it does not eliminate the need for desiccant packaging; a desiccant canister containing silica gel with moisture capacity of 3.0 g per 1 g of water vapor at 25 °C/40% RH may still be required in high-density polyethylene containers, and published data for long-term stability at 25 °C/60% RH should be generated on a product-specific basis.
Direct compression of a moisture-sensitive formulation with erythritol also demands control of residual moisture in the active ingredient and excipient before blending. Erythritol as a crystalline material has low bound water, but incoming lots may still carry 0.1–0.3% w/w loss on drying when tested at 105 °C for 3 h under USP 731. A drying step in a fluid-bed dryer with inlet air dew point below −20 °C and product temperature not exceeding 40 °C can reduce surface moisture without altering the crystal habit. Granulating erythritol by dry granulation using a roller compactor with roll pressure of 40–80 kN and granulator mesh of 1.0–1.5 mm improves flow and controls fines, but the compaction behavior of the granules differs from the powder because the roller compaction step consumes part of the fragmentation capacity. The resulting granules may require a higher main compression force to reach equivalent tensile strength, but the tablet capping tendency can decrease because the elastic recovery of the granulated particles is lower than that of the original crystalline powder. In comparative tableting trials on an instrumented rotary press equipped with 8.00 mm round concave tooling, a direct compression blend based on roller-compacted erythritol granules at 65 wt% often shows a reduction in friability of 30–40% relative to the same formulation using ungranulated erythritol at equal compression force, although published data for this exact formulation is limited and the result is dependent on the feedstock particle size distribution.
The non-hygroscopic property of erythritol can be partially negated by formulation additives. Superdisintegrants such as croscarmellose sodium and sodium starch glycolate are hygroscopic and can raise the equilibrium moisture content of a blend by 1–2% w/w at 60% RH even when erythritol itself contributes almost no moisture. This is an incompatibility boundary that must be managed by reducing disintegrant concentration, by switching to crospovidone, or by segregating the finished tablets in aluminum-aluminum blister packaging with a water vapor transmission rate below 0.3 g/m²/day at 38 °C/90% RH when measured under ISO 15106-2. If a moisture-sensitive active ingredient requires both low water activity and rapid disintegration, the formulation may use an effervescent couple based on citric acid and sodium bicarbonate; this combination accelerates disintegration by gas generation but introduces hygroscopic components and requires compression at low relative humidity below 25% RH. The compaction speed of effervescent erythritol tablets is constrained by the friability threshold, and the tensile strength of the tablets is typically maintained between 1.2 MPa and 2.5 MPa to permit packaging on high-speed blister lines without breakage.
Among the sugar alcohols evaluated for orally disintegrating matrices, erythritol presents a distinctive negative enthalpy of solution of approximately −180 J/g, producing a pronounced cooling sensation on contact with saliva, while its non-hygroscopic character avoids the surface patina that can form on xylitol or sorbitol during storage in partially opened multidose containers. Direct compression orally disintegrating tablets containing erythritol as the major filler require a three-way balance among tablet tensile strength, disintegration time, and oral texture. The principal processing conflict is that increasing compression force above 120 MPa improves friability and edge integrity but pushes disintegration time beyond 30 s when the porosity drops below 0.25. A formulation containing erythritol at 60–75 wt%, mannitol at 10–20 wt%, crospovidone at 4–8 wt%, and a sweetener at 0.5–1.0 wt% typically disintegrates in 20–35 s under USP 701 when compressed to a hardness of 35–60 N on 9.00 mm flat-faced bevel-edged tooling. Below 35 N, the tablets become too fragile for rotary press ejection and subsequent handling; above 60 N, disintegration time may exceed 60 s unless the crospovidone is added extragranularly. The oral cooling effect is perceived more strongly as erythritol content rises above 65 wt%, but this also magnifies the brittle fracture tendency and requires precompression tuning. Published data for the correlation between erythritol solution enthalpy and perceived freshness in direct compression matrices is limited, but the thermophysical data itself is sufficient to support formulation design.
The direct compression of erythritol-based orally disintegrating tablets on a production rotary press is constrained by the absence of granulation moisture and the high elastic recovery of the compact. When a 35-station rotary tablet press is operated at turret speeds of 30–60 rpm with 9.00 mm round B-tooling, the dwell time under main compression falls below 20 ms. Under these conditions, plain erythritol blends may exhibit capping and lamination if the precompression force is below 15% of the main compression force or if the punch penetration depth is outside the specified range for the tooling. The use of a paddle feeder at 20–40 rpm and a die table scraper height of 0.3–0.5 mm reduces segregation and stabilizes die fill, but it does not correct brittle fracture within the compact. Tablet hardness measured immediately after compression can be 10–20% lower than hardness measured after 24 h storage at 25 °C/40% RH because of stress relaxation and internal microcrack closure; this time-dependent change should be anticipated in the hardness release limit. For a direct compression orally disintegrating tablet with a target tensile strength of 1.5 MPa, the immediate post-compression acceptance range should not be set too narrowly, or process operators will reject acceptable batches during the start-up phase.
High-speed rotary compression exposes the brittle fracture mechanism of erythritol to two independent process variables: reduced dwell time and increased punch velocity. As punch velocity increases from 10 mm/s to 200 mm/s on a compaction simulator, the apparent yield pressure of erythritol compacts rises and the compact tensile strength at a given compression force falls by 20–35%. This is the opposite of what is observed with plastic fillers such as microcrystalline cellulose, which maintain or even improve compactibility at higher speeds due to time-dependent deformation. On a production rotary press running at 50 rpm with 10.00 mm B-tooling, the main compression dwell time is often below 15 ms; this dwell is insufficient for stress relaxation in the fragmented erythritol network, and lamination can originate at the tablet band where the radial pressure drops most rapidly during decompression. Process engineers mitigate this by increasing precompression to 25–30% of the main compression force, by reducing turret speed to 30–40 rpm, and by switching from flat-faced to concave tooling with a shallow cup depth of 0.8–1.2 mm. Shallow concave geometry reduces the localized stress concentration at the tablet edge and improves ejection integrity. The use of tapered dies with a taper angle of 1° or less also reduces ejection work and lowers the incidence of edge chipping.
Equipment configuration matters more for erythritol than for plastically deforming fillers. On a rotary press with an overload capacity of 80 kN per station and a maximum precompression force of 15 kN, the compression force required to produce a 2.0 MPa tensile strength tablet from an erythritol-based dry blend may approach 20–30 kN on 10.00 mm round tooling. If the same formulation is compressed on a press with worn punch tips or die bore roughness above 0.2 µm Ra, ejection forces can increase by 30–40% and picking can occur even at acceptable magnesium stearate levels. Punch tip coating with chromium nitride reduces adhesion in long runs, but published comparative data for erythritol-containing formulations across different punch coatings is limited. The lower punch penetration depth should be adjusted so that the compression station enters the main compression phase only after the die is uniformly filled; variations in die fill exceeding ±3% produce visible weight variation and directly increase tablet weight RSD under USP 905. When the formulation contains more than 70 wt% erythritol, the compression force-displacement profile often shows a secondary fragmentation event at higher pressures, visible as a discontinuity in the force-time curve on instrumented tooling; this discontinuity is not necessarily a defect but it indicates that the material is densifying by successive fracture rather than homogeneous deformation.
The practical upper limit for erythritol in a direct compression formulation run at high speed is governed by the tensile strength requirement of downstream packaging. Blister packaging lines with push-through lidding and high-speed vibratory feeding generally require tablets with friability below 0.5% after 100 rotations and breaking force above 50 N for round tablets of 8.00 mm diameter. Plain erythritol cannot reliably meet these limits without a dry binder. A formulation containing erythritol at 60 wt%, microcrystalline cellulose PH102 at 30 wt%, crospovidone at 4 wt%, and magnesium stearate at 0.5 wt% can be compressed on a rotary press at 40 rpm to a breaking force of 70–90 N and friability below 0.3%, with a disintegration time below 10 min. The same formulation with erythritol raised to 80 wt% and microcrystalline cellulose reduced to 10 wt% may compress to 50–65 N breaking force but friability rises to 0.6–0.9% and capping risk increases after extended press runs beyond 4 h. Published data for long-run tooling wear in this formulation is limited, so die table inspections every 30 min during validation are advisable.
In high-dose formulations where erythritol constitutes 50–85 wt% of the tablet core, the compaction behavior is further modified by the active ingredient particle size and the presence of hydrophobic lubricants. If the active ingredient is a fine cohesive powder with a D90 below 30 µm, it fills the interstices between erythritol crystals and can either improve compact strength by increasing contact points or reduce compact strength by coating fragmented surfaces and preventing bonding. The outcome depends on the deformation mechanism of the active: brittle actives reinforce the fragmentation network, while plastic actives can act as local stress absorbers. When magnesium stearate is present at 1.0 wt%, the hydrophobic layer deposited on erythritol fragments lowers the interparticulate contact energy, and tablets may exhibit a 15–25% reduction in tensile strength relative to 0.5 wt% lubricant; the effect is smaller than in microcrystalline cellulose blends but is still measurable. To maintain uniform lubrication without overblending, high-dose formulations are sometimes lubricated using a co-processed erythritol grade in which the lubricant is dispersed within the particle matrix; however, published data for direct compression grades of this type is limited and process validation must confirm the absence of lubricant segregation.